GlassScriptPhysician profile
Meleah Johnston
NPI 1376941286
$2,518.64
in general payments reported to CMS, 2019-2025
19 companies · $39.09 in 2025
The $39.09 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $863 · 2022: $882 · 2023: $645 · 2024: $90.04 · 2025: $39.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $791.92 | 2021-2024 | |
| Merz North America, INC. | $266.22 | 2021-2025 | Xeomin |
| Novartis Pharmaceuticals Corporation | $193.01 | 2021-2023 | |
| Lilly USA, LLC | $180.74 | 2021-2022 | |
| Allergan, INC. | $157.53 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $147.04 | 2021 | |
| Janssen Biotech, INC. | $142.07 | 2021-2023 | Tremfya |
| Sun Pharmaceutical Industries INC. | $112.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $90.16 | 2022-2023 | Sotyktu |
| Galderma Laboratories, L.P. | $70.26 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $64.18 | 2021-2022 | |
| Ucb, INC. | $63.78 | 2021-2023 | Cimzia |
| Incyte Corporation | $54.40 | 2021 | |
| Pfizer INC. | $49.39 | 2021-2023 | |
| Vyne Pharmaceuticals INC. | $48.50 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $30.74 | 2023 | Vtama |
| Amgen INC. | $25.55 | 2023 | Otezla |
| Almirall LLC | $18.98 | 2023 | Klisyri |
| Journey Medical Corporation | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meleah Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.